GO
Loading...

Bristol-Myers Squibb Co

More

  • Final Glance: Pharmaceuticals companies Tuesday, 2 Sep 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 69 or. 9 percent, to $74.29. Bristol-Myers Squibb Co. fell$. 07 or. 1 percent, to $50.58. Hospira rose$. 48 or. 9 percent, to $54.22.

  • Midday Glance: Pharmaceuticals companies Tuesday, 2 Sep 2014 | 1:22 PM ET

    Baxter International Inc. fell$. 69 or. 9 percent, to $74.29. Bristol-Myers Squibb Co. fell$. 23 or. 5 percent, to $50.42. Hospira rose$. 25 or. 5 percent, to $53.99.

  • Early Glance: Pharmaceuticals companies Tuesday, 2 Sep 2014 | 10:57 AM ET

    Baxter International Inc. fell$. 06 or. 1 percent, to $74.92. Bristol-Myers Squibb Co. fell$. 39 or. 8 percent, to $50.26. Hospira rose$. 41 or. 8 percent, to $54.15.

  • *Novartis's LCZ696 and PCSK9 drugs could treat millions. Hopes have spiked for a heart failure drug from Novartis and an innovative class of injectable anti-cholesterol agents known as PCSK9 inhibitors after the release of data at the ESC's annual meeting indicated that they can save more lives than standard therapies.

  • Final Glance: Pharmaceuticals companies Friday, 29 Aug 2014 | 6:07 PM ET

    Baxter International Inc. rose$. 07 or. 1 percent, to $74.98. Bristol-Myers Squibb Co. rose$. 11 or. 2 percent, to $50.65. Hospira fell$. 48 or. 9 percent, to $53.74.

  • Midday Glance: Pharmaceuticals companies Friday, 29 Aug 2014 | 1:19 PM ET

    Baxter International Inc. rose$. 08 or. 1 percent, to $74.99. Bristol-Myers Squibb Co. fell$. 01 or percent, to $50.53. Eli Lilly& Co. rose$. 04 or. 1 percent, to $63.15.

  • Early Glance: Pharmaceuticals companies Friday, 29 Aug 2014 | 10:31 AM ET

    Baxter International Inc. fell$. 27 or. 4 percent, to $74.64. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $50.38. Hospira fell$. 09 or. 2 percent, to $54.13.

  • *AstraZeneca shares up 2 percent. LONDON, Aug 29- Hopes for AstraZeneca's promising cancer drug pipeline were boosted on Friday by news the company had moved its immuno-oncology medicine MEDI-4736 into a mid-stage study in colorectal cancer.

  • Final Glance: Pharmaceuticals companies Thursday, 28 Aug 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 43 or. 6 percent, to $74.91. Bristol-Myers Squibb Co. rose$. 29 or. 6 percent, to $50.54. Hospira fell$. 02 or percent, to $54.22.

  • Midday Glance: Pharmaceuticals companies Thursday, 28 Aug 2014 | 1:19 PM ET

    Baxter International Inc. fell$. 38 or. 5 percent, to $74.96. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $50.64. Hospira rose$. 01 or percent, to $54.25.

  • Early Glance: Pharmaceuticals companies Thursday, 28 Aug 2014 | 10:31 AM ET

    Baxter International Inc. fell$. 47 or. 6 percent, to $74.87. Bristol-Myers Squibb Co. rose$. 24 or. 5 percent, to $50.49. Hospira fell$. 14 or. 3 percent, to $54.10.

  • Final Glance: Pharmaceuticals companies Wednesday, 27 Aug 2014 | 6:02 PM ET

    Baxter International Inc. fell$. 19 or. 3 percent, to $75.34. Bristol-Myers Squibb Co. fell$. 52 or 1.0 percent, to $50.25. Hospira rose$. 20 or. 4 percent, to $54.24.

  • Early Glance: Pharmaceuticals companies Wednesday, 27 Aug 2014 | 10:18 AM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $75.03. Bristol-Myers Squibb Co. fell$. 50 or 1.0 percent, to $50.27. Hospira rose$. 04 or. 1 percent, to $54.08.

  • Final Glance: Pharmaceuticals companies Tuesday, 26 Aug 2014 | 6:05 PM ET

    Baxter International Inc. rose$. 13 or. 2 percent, to $75.53. Bristol-Myers Squibb Co. rose$. 04 or. 1 percent, to $50.77. Hospira fell$. 56 or 1.0 percent, to $54.04.

  • Midday Glance: Pharmaceuticals companies Tuesday, 26 Aug 2014 | 1:31 PM ET

    Baxter International Inc. rose$. 12 or. 2 percent, to $75.52. Bristol-Myers Squibb Co. fell$. 02 or percent, to $50.71. Hospira fell$. 22 or. 4 percent, to $54.38.

  • Aug 26- Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck& Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy. The largest U.S. drugmakers said the combination study will begin in 2015 and be conducted by Pfizer.

  • Early Glance: Pharmaceuticals companies Tuesday, 26 Aug 2014 | 11:12 AM ET

    Baxter International Inc. rose$. 06 or. 1 percent, to $75.46. Bristol-Myers Squibb Co. rose$. 12 or. 2 percent, to $50.85. Johnson& Johnson rose$. 06 or. 1 percent, to $103.29.

  • Final Glance: Pharmaceuticals companies Monday, 25 Aug 2014 | 6:24 PM ET

    Baxter International Inc. rose$. 36 or. 5 percent, to $75.40. Bristol-Myers Squibb Co. rose$. 55 or 1.1 percent, to $50.73. Johnson& Johnson rose$. 13 or. 1 percent, to $103.23.

  • Early Glance: Pharmaceuticals companies Monday, 25 Aug 2014 | 10:37 AM ET

    Baxter International Inc. rose$. 45 or. 6 percent, to $75.49. Bristol-Myers Squibb Co. rose$. 34 or. 7 percent, to $50.52. Hospira rose$. 28 or. 5 percent, to $54.88.

  • LOS ANGELES, Aug 25- U.S. regulators are likely to approve Merck& Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation.